Sushil Patel Replimune Group, Inc. (REPL) insider trading activity

Sushil Patel is Chief Executive Officer of Replimune Group, Inc.. Currently has a direct ownership of 533,576 shares of REPL, which is worth approximately $4.8 Million. The most recent transaction as insider was on Dec 19, 2025, when has been sold 200,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 534K

55.3% 3M change

164.13% 12M change

Total Value Held $4.8 Million

Sushil Patel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 19 2025	BUY Grant, award, or other acquisition	-	200,000 Added 27.26%	533,576 Common Stock
Dec 02 2025	SELL Open market or private sale	$111,300 $11.13 p/Share	10,000 Reduced 2.91%	333,576 Common Stock
May 20 2025	SELL Open market or private sale	$202,346 $8.06 p/Share	25,105 Reduced 6.81%	343,576 Common Stock
Apr 01 2025	BUY Grant, award, or other acquisition	-	166,667 Added 31.13%	368,681 Common Stock
Dec 16 2024	SELL Open market or private sale	$124,200 $12.42 p/Share	10,000 Reduced 4.72%	202,014 Common Stock
May 16 2024	SELL Open market or private sale	$130,655 $6.47 p/Share	20,194 Reduced 8.7%	212,014 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	-	83,335 Added 26.41%	232,208 Common Stock

Jun 13 2023	SELL Open market or private sale	$135,498 $23.78 p/Share	5,698 Reduced 3.69%	148,873 Common Stock
May 16 2023	SELL Open market or private sale	$281,128 $18.05 p/Share	15,575 Reduced 9.15%	154,571 Common Stock
Apr 01 2023	BUY Grant, award, or other acquisition	-	40,000 Added 19.03%	170,146 Common Stock
May 16 2022	SELL Open market or private sale	$155,923 $14.59 p/Share	10,687 Reduced 7.59%	130,146 Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	-	52,500 Added 27.16%	140,833 Common Stock
May 03 2021	BUY Grant, award, or other acquisition	-	88,333 Added 50.0%	88,333 Common Stock

Also insider at

RVMD

Revolution Medicines, Inc. Healthcare

Sushil Patel

Chief Executive Officer

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REPL shares.

Notify only if

Value

Insider Trading

Get notified when an Replimune Group, Inc. insider buys or sells REPL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Replimune Group, Inc.

Track Activities on REPL

Account